跳至主要内容
临床试验/NCT05625503
NCT05625503已完成早期 1 期

Does Dilution of Verapamil With Normal Saline or Blood Reduce Discomfort Felt During Intraarterial Administration?

University of Illinois at Chicago1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2022年12月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
55
试验地点
1
主要终点
Radial Artery Spasm

研究概览

简要总结

This study will be a randomized, single-blind, prospective trial designed to evaluate the efficacy and safety of intra-arterial (IA) Verapamil diluted with normal saline compared to undiluted IA Nicardipine during transradial access (TRA) for percutaneous coronary angiography. Patients who are 18 years or older and undergoing non-emergent percutaneous coronary angiography via TRA will be included. Patients who are non-English speaking, pregnant, or intubated will be excluded. Patients will be randomized to one of the two following groups:

  1. Group 1 will receive IA Verapamil 5 mg (2mL) diluted with 8 mL of normal saline
  2. Group 2 will receive IA Nicardipine 400 mcg (undiluted, 8 mL)

The investigators will document the patient's level of discomfort on the Visual Analogue Scale 30 seconds before and after administration of IA Verapamil/Nicardipine. The investigators will also document the presence of radial artery spasms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Verapamil

Active Comparator

Intra-arterial Verapamil 5 mg (2mL) diluted with 8 mL of normal saline

干预措施: Verapamil (Drug)

Nicardipine

Placebo Comparator

Intra-arterial Nicardipine 400 mcg undiluted (8mL)

干预措施: Nicardipine (Drug)

结局指标

主要结局

Radial Artery Spasm

时间窗: approximately 30 minutes

The investigators will document the presence or absence of radial artery spasms with either 0,1, or 2. 0 will indicate no radial artery spasms. 1 will indicate radial artery spasms that did not require a change in strategy. 2 will indicate radial artery spasms that required a change in strategy such as alternate access.

Pain Prior to Intra-arterial Calcium Channel Blocker Administration

时间窗: 30 seconds prior to administration

Pain prior to intra-arterial calcium channel blocker administration will be assessed through the Visual Analogue Pain scale (from 0 to 10).

Pain After Intra-arterial Calcium Channel Blocker Administration

时间窗: 30 seconds post administration

Pain after intra-arterial calcium channel blocker administration will be assessed through the Visual analogue Pain Scale (from 0 to 10).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Khalil Ibrahim

Assistant Professor of Clinical Medicine

University of Illinois at Chicago

研究点 (1)

Loading locations...

相似试验